AUS
NZ
UK
CA
USA
IND
Health
Amneal Pharmaceuticals (NASDAQ:AMRX) Maintains Market Presence in Healthcare
January 31, 2025 09:10 AM PST| By Team Kalkine MediaHighlights,SG Americas Securities LLC raised its Amneal stake by 16.7%.,Executives transacted shares in recent months.,Financial firms gave mixed ratings.,Amneal Pharmaceuticals, Inc. Class A Common Stock is part of,NYSE Healthcare Stocks,and has see...
Financial Backing Strengthens Catalyst Pharmaceuticals (NASDAQ:CPRX) Presence
January 31, 2025 09:05 AM PST| By Team Kalkine MediaHighlights,Catalyst Pharmaceuticals sees rising institutional interest.,Stock performance remains steady in the biopharmaceutical sector.,Strong presence in rare disease treatments supports growth.,Catalyst Pharmaceuticals Inc. is part of,NASDAQ Heal...
SG Americas Securities LLC holds a $596,000 stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN).
January 31, 2025 12:29 AM PST| By Team Kalkine MediaViridian Therapeutics Sees Major Institutional Investments and Ongoing Development in Therapeutics
Market Sentiment and Institutional Participation in Perrigo (NYSE:PRGO)
January 31, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Institutional firms control 95.91% of Perrigo Company plc.,Financial firms revised ratings, adjusting price targets.,Perrigo reported stable earnings per share despite a slight revenue decline.,Perrigo Company PLC is part of,NYSE Healthca...
Market Developments and Research Initiatives at Rocket Pharmaceuticals (NASDAQ:RCKT)
January 31, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,SG Americas Securities LLC raised its Rocket Pharmaceuticals stake by 796.2%.,CEO Gaurav Shah completed a stock transaction.,Rocket Pharmaceuticals expands its gene therapy pipeline.,Rocket Pharmaceuticals Inc. is part of,NASDAQ Healthcare...
Leadership Stock Transactions and Business Strategy at Progyny (NASDAQ:PGNY)
January 31, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,SG Americas Securities LLC reduced its Progyny stake by 33.6% in Q4.,Institutional firms adjusted positions, with notable stake increases and new entries.,Financial firms revised price targets, reflecting mixed market sentiment.,Progyny In...
Carisma Therapeutics: A Closer Look at NASDAQ:CARM
January 30, 2025 11:24 PM PST| By Team Kalkine MediaCarisma Therapeutics: A Closer Look at NASDAQ:CARM
ProQR Therapeutics: Navigating Stock Performance and Market Trends
January 30, 2025 11:24 PM PST| By Team Kalkine MediaProQR Therapeutics: Navigating Stock Performance and Market Trends
CVRx Navigates Financial Challenges with Strong Institutional Support
January 30, 2025 11:23 PM PST| By Team Kalkine MediaCVRx: Navigating the Dynamics of a Medical Device Innovator
Vaxcyte: A Closer Look at Recent Developments and Market Position
January 30, 2025 11:23 PM PST| By Team Kalkine MediaVaxcyte: A Closer Look at Recent Developments and Market Position
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of "Moderate"
January 30, 2025 11:22 PM PST| By Team Kalkine MediaCareDx's Strategic Developments and Market Position Analysis
United-Guardian's Stock Volatility and Institutional Interest Highlight Growth Potential
January 30, 2025 11:22 PM PST| By Team Kalkine MediaUnited-Guardian's Stock Volatility and Institutional Interest Highlight Growth Potential
Quest Diagnostics (NYSE:DGX) Hits New 12-Month Peak After Impressive Earnings Report
January 30, 2025 10:28 PM PST| By Team Kalkine MediaQuest Diagnostics: Strong Performance and Strategic Growth
Veracyte (NASDAQ:VCYT) Reaches New 52-Week High Following Analyst Upgrade
January 30, 2025 10:28 PM PST| By Team Kalkine MediaVeracyte Achieves New Heights Amid Expert Upgrades
Why Are Eyes Suddenly Turning to This Previously Ignored Stock?
January 30, 2025 12:36 AM PST| By Team Kalkine MediaHighlights:,HCA Healthcare maintains a diverse brokerage landscape with varied ratings and target prices.,Active insider and institutional movements influence stock ownership trends.,Recent strong financial performance, including a robust earnings re...
Chimerix (NASDAQ:CMRX) Share Price Surpasses 200-Day Moving Average – Here's the Reason Why
January 30, 2025 12:28 AM PST| By Team Kalkine MediaHighlights:,Chimerix shares rise above 200-day moving average, reflecting growing market activity.,The company's focus remains on advancing its clinical pipeline, including ONC201 in Phase 3 trials.,Strong institutional backing with recent stake incr...
Orthofix Medical (NASDAQ:OFIX) Balances Market Expansion with Financial Strength
January 30, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Analyst upgrades reflect increased confidence in company performance.,Institutional participation remains strong with significant holdings.,Global operations support product expansion in orthopedic solutions.,Orthofix Medical Inc. is part...
Biopharmaceutical Developments and Stock Trends at ZyVersa (NASDAQ:ZVSA)
January 30, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Short interest in ZyVersa rise by 1,291% in January.,The stock fluctuated between $25.00 and $0.98 in the past year.,ZyVersa advances drug development for renal and inflammatory diseases.,ZyVersa Therapeutics Inc. is part of,NASDAQ Healthc...
Galmed Pharmaceuticals (NASDAQ:GLMD) Strengthens Research and Development
January 30, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,New coverage brings market attention to Galmed Pharmaceuticals.,Stock fluctuations observed amid ongoing company developments.,Aramchol drug progress continues in liver disease treatment research.,Galmed Pharmaceuticals Ltd. is part of,NAS...
Johnson & Johnson (NYSE:JNJ) Stock Moves Lower Despite Solid Earnings
January 29, 2025 10:37 AM PST| By Team Kalkine MediaHighlights,Johnson & Johnson stock drops 0.6%, reaching a price of $151.90.,The company’s quarterly earnings surpass expectations, though revenue falls slightly short.,Johnson & Johnson announces a quarterly dividend payout with a yield of 3.29%.,Joh...
